3136 results for «3096»

Filter By

3136 results

TAVI complications

21 Nov 2021 – From PCR London Valves 2021

Watch this session from PCR London Valves 2021 to appreciate the hybrid management of double aortic root rupture complicating TAVI, learn about an unexpected cause for complication during TAVR, investigate acute left main occlusion during TAVI, and much more!

TAVI complications

New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management

21 Nov 2021 – From PCR London Valves 2021

Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...

New 2021 ESC heart failure

TAVI valve and implantation technique: the secrets for optimising outcomes

21 Nov 2021 – From PCR London Valves 2021

Join Neil Moat, Helge Möllmann, Lars Søndergaard and Ganesh Manoharan to hear the experience of an account achieve single digit permanent pacemaker implantation, to learn how to preserve coronary access for future patients' treatment, and to see how new product features can reduce paravalvular leak.

TAVI valve and implantation

Closing TAVI with next generation suture mediated closure device

21 Nov 2021 – From PCR London Valves 2021

Join Francesco Maisano to learn more about about the Perclose ProStyle, a next generation closure device for TAVI procedures, and discover some interesting tips & tricks.

Closing TAVI with next

The science behind a valve designed for life

21 Nov 2021 – From PCR London Valves 2021

Join Christopher Meduri if you want to understand the features of a transcatheter heart valve that is designed to last the life of the patient, why a 3D single-piece aortic valve design can provide near normal pre-disease hemodynamics and how tissue science impacts leaflet preservation and...

The science behind a

PCR London Valves innovations

21 Nov 2021 – From PCR London Valves 2021

Discover the first-in-man experience with a mitral D-shaped semi-rigid annuloplasty system, find out more about the novel 3D single-piece transcatheter valve designed for lifetime patient management, know more about the first dedicated transcatheter leaflet splitting device from bench to FIH, and much more in this session...

PCR London Valves innovations

A heart-team discussion for tricuspid valve intervention

21 Nov 2021 – From PCR London Valves 2021

Join Vinayak Bapat, Joao Cavalcante and Paul Sorajja to learn about how the heart-team approaches tricuspid valve intervention, how to pre-procedurally plan transcatheter tricuspid valve repair/replacement and how to intra-operatively guide TTVR using imaging.

A heart-team discussion

Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves (COMALIGN)

21 Nov 2021 – From PCR London Valves 2021

Join Lars Søndergaard and Ole De Backer if you want to learn about why patient-specific implantation techniques are important to obtain commissural alignment, which imaging techniques are needed to achieve commissural alignment, as well as how valve and delivery system designs impact outcomes and success rates.

Patient-specific implantation

Early neo2 registry - Full core-lab adjudicated results with the new ACURATE neo2 valve

21 Nov 2021 – From PCR London Valves 2021

Join Won-Keun Kim and Andreas Rück if you want to learn about the key features of the new ACURATE neo2 system, the latest clinical outcomes in an all-comers European patient population, as well as the independent core-lab adjudicated hemodynamic performance of this new TAVI generation.

Early neo2 registry -

Periprocedural outcomes of MANTA vascular closure device used in large-bore arterial access following VARC-3 definitions. More scientific evidence behind plug-based vascular closure device

21 Nov 2021 – From PCR London Valves 2021

Join Simon Redwood, Radoslaw Parma and Nicolas Van Mieghem if you want to learn about the results of the latest 120 patient MANTA registry, the best practices comparing to similar registries of the past, as well as tips and tricks on how to use MANTA vascular...

Periprocedural outcomes

Clinical scenarios

21 Nov 2021 – From PCR London Valves 2021

The PCR London Valves 2021 session offers a variety of interesting clinical scenarios, including a chimney stent as a coronary protection technique in TAVI, an acquired thrombocytopenia after TAVR to predict adverse outcomes, or even a calcified raphe predict adverse effect in bicuspid aortic stenosis patients...

Clinical scenarios

A low-risk patient with a bicuspid type 0 aortic stenosis

18 May 2021 – From EuroPCR 2021

How would you treat an 82-year-old male patient presented with dyspnoea NYHA III who is also found to have IPMN? View this session to analyze the authors' decision!

A low-risk patient with a bicuspid type 0 aortic stenosis

TAVI procedure optimisation with the cusp overlap technique

27 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...

TAVI procedure optimisation with the cusp overlap technique

Addressing the challenges of small annuli patients with the Evolut Platform

27 Sep 2021 – From PCR Tokyo Valves 2021

Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...

Addressing the challenges of small annuli patients with the Evolut Platform

Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology

27 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...

Introducing Navitor:

Contemporary procedural practice for TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to learn more about contemporary procedural practice for TAVI: discover the impact of the COVID-19 pandemic on TAVI programmes worldwide, the steps of contemporary transfemoral TAVI with tips and tricks, as well as the rules for early discharge post TAVI.

Contemporary procedural practice for TAVI

Case-based challenging heart team decisions in combined structural heart diseases

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this case-based session on combined structural heart diseases to discover what is the heart team approach for complex structure heart diseases, as well as how to manage a patient with multiple diseases.

Case-based challenging heart team decisions in combined structural heart diseases

Valve-in-valve TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.

Valve-in-valve TAVI

Edge-to-edge mitral repair

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on edge-to-edge mitral repair to learn more about the indication and the patient selection for percutaneous mitral valve treatment for secondary MR, and discover some interesting tips and tricks in difficult situations during MitraClip.

Edge-to-edge mitral repair

TAVI and coronary artery disease

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.

TAVI and coronary artery disease
Didn’t find what you were looking for?